ID: ALA3347506

Max Phase: Preclinical

Molecular Formula: C19H16N4O

Molecular Weight: 316.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1c2ncccc2-c2nccc3c(N4CCCCC4)cnc1c23

Standard InChI:  InChI=1S/C19H16N4O/c24-19-17-13(5-4-7-20-17)16-15-12(6-8-21-16)14(11-22-18(15)19)23-9-2-1-3-10-23/h4-8,11H,1-3,9-10H2

Standard InChI Key:  WRGYMSQAWROLSQ-UHFFFAOYSA-N

Associated Targets(Human)

A-427 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 316.36Molecular Weight (Monoisotopic): 316.1324AlogP: 3.23#Rotatable Bonds: 1
Polar Surface Area: 58.98Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.54CX LogP: 2.56CX LogD: 2.56
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.54Np Likeness Score: 0.01

References

1. Chen JL, Sperry J, Ip NY, Brimble MA.  (2011)  Natural products targeting telomere maintenance,  (4): [10.1039/C0MD00241K]

Source